Get With The Guidelines-Stroke Participation Has Improved Stroke Care

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 31, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 31, 2024 -- For patients with stroke and transient ischemic attack, The Get With The Guidelines-Stroke participation is associated with sustained improvement in care and outcomes, according to a study published online Oct. 21 in Stroke.

Ying Xian, M.D., Ph.D., from UT Southwestern Medical Center in Dallas, and colleagues examined patient characteristics, adherence to performance measures, and in-hospital outcomes in patients hospitalized with stroke in The Get With The Guidelines-Stroke hospitals from 2003 to 2022. Temporal changes in performance measure adherence and clinical outcomes were quantified over time.

A total of 7,837,849 stroke cases were entered into the registry during the 20 years of the program: 69.2 percent ischemic strokes, 3.9 percent subarachnoid hemorrhages, 11.5 percent intracerebral hemorrhages, and 15.3 percent transient ischemic attacks. The researchers found significantly sustained improvements in all performance metrics except for antithrombotics at discharge (baseline performance >92 percent), regardless of type of cerebrovascular event. Independent of patient and hospital characteristics for each type of cerebrovascular event, there was a sustained increase in odds of receiving each performance measure over time in a multivariable analysis. There were temporal trends that patients were less likely to be discharged to a skilled nursing facility after risk adjustment; for ischemic stroke only, they were more likely to be discharged directly home.

"These findings provide compelling evidence to support continuous efforts in improving stroke care and outcomes in the United States and globally," the authors write.

Several authors disclosed ties to the pharmaceutical industry; The Get With The Guidelines-Stroke program is sponsored by pharmaceutical companies.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-01 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords

AI Assitant